KZA kazia therapeutics limited

I see another PI3K inhibitor being developed which can also...

  1. 1,734 Posts.
    lightbulb Created with Sketch. 543
    I see another PI3K inhibitor being developed which can also cross the BBB. Planning to enter the clinic in 2024 in TNBC patients.

    So miles behind, but may look to take market share in future (if PAX ever makes it to market).

    https://globalcancertechnology.com/
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.